Vés al contingut

Ma Teresa Quiles Pérez

Institucions de les que formen part

Investigador/a sènior
Cirurgia general
Vall Hebron Institut de Recerca

Ma Teresa Quiles Pérez

Institucions de les que formen part

Investigador/a sènior
Cirurgia general
Vall Hebron Institut de Recerca

Línies de recerca

Abdominal Wall. Biomaterials and bioengineering

Research focus

The reconstruction of abdominal wall defects is the problem with which surgeons are confronted more often. These defects may have an acute (trauma, cancer, infections) or chronic (hernia pathology) origin. Despite technical advances, the specific pathomechanisms and diverse treatment aspects remain controversial. In this line, surgeons and basic researchers work closely with other specialists (including pathologists, microbiologists, mathematicians and engineers) to better understand the promoting forces that trigger hernia formation and tissue rupture, from a mechanistic point of view. The studies are based on patient-derived tissue samples and primary fibroblasts, as well as on surgically-induced experimental models. Moreover, soft-tissue repair devices are being investigated by means of “in vitro” and “in vivo” experimental models. Quality care and surgical outcomes research studies are also developed.


Sub-lines


Basic Research


1. Extracellular matrix, inflammation and cell death induction in abdominal wall defects. This line focuses on the role of cell-extracellular matrix (ECM) interactions in the fields of inflammation and tissue repair. Recent data from our laboratory provide compelling evidence on how the local ECM may

influence incisional hernia development. They suggest that fascia atrophy may be an active driver of the disease, by means of transducing signals that affect cell survival, functional phenotype, and (probably) gene expression. Also, they identify fibroblasts and cell fragility as major pathogenic contributors to incisional hernia formation. The accumulation of apoptotic-prone defective fascia fibroblasts may not support normal fascial structure and function, and thus enhance proteolytic fascial destruction in a context of low cell proliferation. Currently, we are investigating changes in subsets of genes from incisional hernia derived primary fibroblasts.


2. Biomaterials and soft tissue repair. Current surgical practice supports the use of permanent prosthetic meshes as the best method for hernia repair. Still, no material has gained a preference for universal use and numerous complications are still reported. This line analyzes different new generation materials for soft-tissue (self-)repair. Our approach includes the characterization of the devices surface and biomechanics, as well as the analyses of host cell-substrate interactions, by means of “in-vitro” (primary fibroblasts derived from control and IH patients) and “in-vivo” (rats) experimental models. The ultimate goal is to impact on the development of new tailored implants based on fibroblasts and biomimetic materials, which are clinically useful to mend damaged tissues.



Clinical research


3. To improve quality care and outcome procedures in the field of abdominal wall surgery, several aspects are evaluated from a clinical point of view: 1. Quality care procedures after elective and emergency hernia surgery, and patients’ follow-ups (outpatient visits, telephone, utili ty of a postal questionnaire); 2. Prevention and treatment of hernias (periostomal, incisional, and inguinal), and their related complications; Implementation of new technical procedures, such as the use of new-generation prosthetic materials and sutures, components’ separation technique (open/endoscopic); pre-peritoneal prosthetic mesh use in the treatment of inguinal hernia; hernia laparoscopic surgery; application of progressive pneumoperitoneum in the treatment of giant incisional hernias, etc.; 3. Biomaterials: validation of new architectures and designs (polymer scaffolds; extracellular matrix-derived biological implants; biodegradable and bioactive –ie, antibacterial properties- grafts); 4. Virtual Reality (in collaboration with the Universitat Rovira i Virgili, Tarragona, (URV), and the Universitat Politècnica de Catalunya (UPC)): Abdominal’s wall virtual simulation, for clinical and educational purposes; 5. Surgical Sutures (European Project).

IP: Maria Antonia Arbos Via, Manuel Armengol Carrasco, Manuel López Cano, Ma Teresa Quiles Pérez

Projectes

GRUP DE RECERCA EN CIRURGIA GENERAL (GRCG-VHIR)

IP: Maria Antonia Arbos Via
Col·laboradors: Oscar González López, Amador Garcia Ruiz de Gordejuela, Manuel López Cano, Jose Luis Sánchez García, Iñigo Royo Crespo, Jordi Sabadell García, Laura Maria Romero Vielva, Ma Teresa Quiles Pérez, Francesc Vallribera Valls, Nivardo Rodríguez Conde, Marc Martí Gallostra, Manuel Armengol Carrasco, Eloy Espín Basany, Mireia Verdaguer Tremolosa, Sandra Castro Boix, Ramón Vilallonga Puy, Alberto Jauregui Abularach, Franco Marinello, Enric Caubet Busquet, Alejandro Solis Peña
Entitat finançadora: Agència Gestió Ajuts Universitaris i de Recerca
Finançament: 0.01
Referència: 2021 SGR 00210
Durada: 01/01/2022 - 31/12/2024

Alteraciones biomoleculares en la matriz extracelular como herramienta para establecer nuevos perfiles de pacientes y predicción de respuesta a cirugía bariátrica. Estudio en humanos y ratas.

IP: Enric Caubet Busquet
Col·laboradors: Oscar González López, Ma Teresa Quiles Pérez, Andreea Ciudin Mihai, Esther Gil Barrionuevo, Maria Antonia Arbos Via
Entitat finançadora: Instituto de Salud Carlos III
Finançament: 122815
Referència: PI17/01879
Durada: 01/01/2018 - 30/06/2022

Interacción de biomateriales y fibroblastos disfuncionales de tejidos humanos comprometidos. Tratamientos superficiales de polímeros actuales utilizados en la reparación de tejidos blandos.

IP: Manuel Armengol Carrasco
Col·laboradors: Manuel López Cano, Jordi Sabadell García, Ma Teresa Quiles Pérez, Sabina Salicrú Riera, Maria Antonia Arbos Via
Entitat finançadora: Instituto de Salud Carlos III
Finançament: 116765
Referència: PI17/01236
Durada: 01/01/2018 - 30/06/2022

Cirurgia General (GRC)

IP: Manuel Armengol Carrasco
Col·laboradors: Oscar González López, Manuel López Cano, Jose Luis Sánchez García, Jordi Sabadell García, Laura Maria Romero Vielva, María Deu Martín, Ma Teresa Quiles Pérez, Francesc Vallribera Valls, Jose Manuel Fort López-Barajas, Nivardo Rodríguez Conde, Irene Bello Rodríguez, Marc Martí Gallostra, Jordi Pradell Teigell, Eloy Espín Basany, Sandra Castro Boix, Ramón Vilallonga Puy, Alberto Jauregui Abularach, Maria Antonia Arbos Via, Enric Caubet Busquet
Entitat finançadora: Agència Gestió Ajuts Universitaris i de Recerca
Finançament: 30000
Referència: 2014 SGR 1075
Durada: 01/01/2014 - 31/12/2016

Notícies relacionades

Aquesta patologia, comú entre pacients intervinguts amb una resecció del recte a causa d’un càncer, ocasiona alteracions en la funció intestinal amb un gran impacte en la qualitat de vida.

Una vintena d’investigadors i investigadores participen en xerrades i tallers per apropar la ciència a tothom.

La investigació ha rebut ajuts de la Societat Espanyola de Cirurgia de l’Obesitat i l’Associació Espanyola de Cirurgians.

Professionals relacionats

Marcel Lamana Vallverdu

Marcel Lamana Vallverdu

Tècnic de recerca
Malalties neurovasculars
Llegir més
Sarai Garriga Edo

Sarai Garriga Edo

Investigador/a predoctoral
Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia
Llegir més
Marc Garcia - Elias Cos

Marc Garcia - Elias Cos

Investigador/a principal
Cirurgia reconstructiva de l'aparell locomotor
Llegir més
Rodrigo De Almeida Toledo

Rodrigo De Almeida Toledo

Investigador/a sènior
Llegir més

Subscriu-te als nostres butlletins i forma part de la vida del Campus

El Vall d’Hebron Barcelona Hospital Campus és un parc sanitari de referència mundial on assistència, recerca, docència i innovació es donen la mà.